首页 产品目录 分子砌块 按应用领域 分子与化学生命科学 生化试剂 药物研究试剂 5-(2-乙氧基-5-((4-甲基哌嗪-1-基)磺酰基)苯基)-1-甲基-3-丙基-1,4-二氢-7H-吡唑并[4,3-d]嘧啶-7-酮 2-羟基丙烷-1,2,3-三羧酸盐

5-(2-乙氧基-5-((4-甲基哌嗪-1-基)磺酰基)苯基)-1-甲基-3-丙基-1,4-二氢-7H-吡唑并[4,3-d]嘧啶-7-酮 2-羟基丙烷-1,2,3-三羧酸盐

5-(2-ethoxy-5-((4-methylpiperazin-1-yl)sulfonyl)phenyl)-1-methyl-3-propyl-1,4-dihydro-7H-pyrazolo[4,3-d]pyrimidin-7-one 2-hydroxypropane-1,2,3-tricarboxylate

产品编号 :
Cas No. :
包装规格 纯度 目录价 会员专享价 库存 数量
5g 95% 询价
- +
25g 95% 询价
- +
100g 95% 询价
- +
500g 95% 询价
- +
1kg 95% 询价
- +
晶智化学产品均仅供科研使用。在任何情况下,我们均不提供用于动物或人体用途的产品或服务。

基础信息

CAS No.

171599-83-0

中文名称

5-(2-乙氧基-5-((4-甲基哌嗪-1-基)磺酰基)苯基)-1-甲基-3-丙基-1,4-二氢-7H-吡唑并[4,3-d]嘧啶-7-酮 2-羟基丙烷-1,2,3-三羧酸盐

英文名称

5-(2-ethoxy-5-((4-methylpiperazin-1-yl)sulfonyl)phenyl)-1-methyl-3-propyl-1,4-dihydro-7H-pyrazolo[4,3-d]pyrimidin-7-one 2-hydroxypropane-1,2,3-tricarboxylate

别名

SILDENAFIL CITRATE [MART.] | Wan Ai Ke | 5-(2-ethoxy-5-((4-methylpiperazin-1-yl)sulfonyl)phenyl)-1-methyl-3-propyl-1H-pyrazolo[4,3-d]pyrimidin-7(6H)-one 2-hydroxypropane-1,2,3-tricarboxylate | AKOS015856298 | SILDENAFIL CITRATE (USP MONOGRAPH) | 5-{2-etho

标准英文名

5-(2-ethoxy-5-((4-methylpiperazin-1-yl)sulfonyl)phenyl)-1-methyl-3-propyl-1,4-dihydro-7H-pyrazolo[4,3-d]pyrimidin-7-one 2-hydroxypropane-1,2,3-tricarboxylate

MDL No.

MFCD09026931

分子式

C22H30N6O4S.C6H8O7

分子量

666.23

精确分子量

666.23

SMILES

O=C1N=C(C2=C(OCC)C=CC(S(=O)(N3CCN(CC3)C)=O)=C2)NC4=C1N(C)N=C4CCC.O=C(CC(C(O)=O)(CC(O)=O)O)O

标准SMILES

CN1CCN(CC1)S(=O)(=O)C1=CC(C2NC3=C(C(=O)N=2)N(C)N=C3CCC)=C(C=C1)OCC.OC(=O)C(O)(CC(O)=O)CC(O)=O

用途

Treatment of erectile dysfunction (ED); enhancement of penile erection by inhibiting phosphodiesterase type 5 (PDE5), thereby increasing cyclic guanosine monophosphate (cGMP) levels in the corpus cavernosum, promoting smooth muscle relaxation and blood inflow; used as an oral medication for adult males with erectile dysfunction, typically administered at a dose of 50 mg once daily as needed, approximately 1 hour before sexual activity, with a maximum dose of 100 mg per administration; also exhibits potential in preventing or reversing vascular remodeling and enhancing nitric oxide (NO)-mediated vasodilation; investigated for applications in pulmonary vascular diseases due to its PDE5 inhibitory activity.

InChIKey

DEIYFTQMQPDXOT-UHFFFAOYSA-N

安全信息

SureRoute逆合成路线

1.  171599-83-0 逆合成路线 1

ACFLYM607
224785-91-5
ACEWHY816
171596-29-5
现货
ACINAI313
171599-83-0
来源: SureRoute

2.  171599-83-0 逆合成路线 2

—
—
ACINAI313
171599-83-0
来源: SureRoute

3.  171599-83-0 逆合成路线 3

ACZJQD127
139756-02-8
—
—
ACINAI313
171599-83-0
来源: SureRoute
评论 0
我是晶智Agent,
您的化学小助手